Dave Dolby

Authentic Vision GmbH provides brand protection and customer communication solutions. The company was founded by Thomas Weiß and Jürgen Mathwich in 2012 and is headquartered in Salzburg, Austria.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Authentic Vision GmbH provides brand protection and customer communication solutions. The company was founded by Thomas Weiß and Jürgen Mathwich in 2012 and is headquartered in Salzburg, Austria.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Dolby Family Ventures (Dolby) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Authentic Vision GmbH provides brand protection and customer communication solutions. The company was founded by Thomas Weiß and Jürgen Mathwich in 2012 and is headquartered in Salzburg, Austria.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Dolby Family Ventures (Dolby) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Authentic Vision GmbH provides brand protection and customer communication solutions. The company was founded by Thomas Weiß and Jürgen Mathwich in 2012 and is headquartered in Salzburg, Austria.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Dolby Family Ventures (Dolby) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

Tipping Point Community is a non-profit organization based in the Bay Area. The American company's mission is to break the cycle of poverty for people who lack the resources to meet their basic needs. Since 2005, Tipping Point has invested in housing, early childhood, education, and employment solutions in the region. The non-profit company's board covers 100% of its operating costs, ensuring that every dollar donated goes where it's needed most. Tipping Point's grantees provided life-changing services to more than 500,000 people in the region last year, helping over 130,000 people on a path out of poverty. The company was founded by Daniel Lurie, who has been the CEO since incorporation.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.